China Pharma Holdings (CPHI) Interest Coverage Ratio (2010 - 2026)
China Pharma Holdings (CPHI) reported Interest Coverage Ratio of 122.98 for Q1 2026, down 10.02% on a YoY basis from 136.68 in Q1 2025, and down 168.11% quarter-over-quarter from 180.55 in Q4 2025.
China Pharma Holdings (CPHI) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
China Pharma Holdings has reported Interest Coverage Ratio for 17 years, with the latest figure at 122.98 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 10.02% year-over-year to 122.98; the trailing twelve-month figure through Mar 2026 stood at 39.12 (down 3.95% YoY), and the FY2025 full-year result was 29.22, up 32.5% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 122.98, down from 180.55 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 324.72 in Q4 2024, with the low at 203.08 in Q2 2024.
- Historically, Interest Coverage Ratio has averaged 32.5 across 5 years, with a median of 51.39 in 2022.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio jumped 1523.64% — and 2024, when it slumped 6026.77%.
- China Pharma Holdings' Interest Coverage Ratio stood at 5.75 in 2022, then jumped by 1523.64% to 81.85 in 2023, then jumped by 296.73% to 324.72 in 2024, then plunged by 44.4% to 180.55 in 2025, then sank by 168.11% to 122.98 in 2026.
- The last three Interest Coverage Ratio figures came in at 122.98 (Q1 2026), 180.55 (Q4 2025), and 92.4 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -2.31 |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 16.72 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | China Pharma Holdings | 19.13 Mn | 18.97 Mn | 285,487.00 | -122.98 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122.98 |
| Dec 31, 2025 | 180.55 |
| Sep 30, 2025 | -92.40 |
| Jun 30, 2025 | -96.20 |
| Mar 31, 2025 | -111.78 |
| Dec 31, 2024 | 324.72 |
| Sep 30, 2024 | -158.59 |
| Jun 30, 2024 | -203.08 |
| Mar 31, 2024 | -133.61 |
| Dec 31, 2023 | 81.85 |
| Sep 30, 2023 | -10.77 |
| Jun 30, 2023 | -3.31 |
| Mar 31, 2023 | -5.00 |
| Dec 31, 2022 | -5.75 |
| Sep 30, 2022 | -51.39 |
| Jun 30, 2022 | -137.35 |
| Mar 31, 2022 | -7.33 |
| Dec 31, 2021 | -13.90 |
| Sep 30, 2021 | -11.75 |
| Jun 30, 2021 | -10.40 |